Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01370122 · ClinicalTrials.gov registry record
Pelvic Floor Disorders in Survivors of Gynecologic Malignancies
A clinical trial, sponsored by Abramson Cancer Center at Penn Medicine.
- Completed
- Registry status
- 225
- Enrollment target
NCT01370122 is a clinical trial that has completed, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 225 participants.
The verdict
NCT01370122 has completed, sponsored by Abramson Cancer Center at Penn Medicine.
- COMPLETED
- Registry status
- 225 participants
- Enrollment target
Study Summary
Pelvic Floor dysfunction affects the quality of life of women. However, the prevalence and risk factors for pelvic floor disorders (PFD) in survivors of gynecologic malignancies are not known. The investigators plan to perform an observational study including survivors of gynecologic malignancies. Questionnaires for diagnosis of pelvic floor disorders will be mailed to survivors to generate prevalence rates and risk factors for PFD in women with a history of a gynecologic cancer diagnosis.
Interventions
- OTHER Survey
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 225 participants |
| Start Date | 2011-05 |
| Est. Completion | 2017-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01370122
The ClinicalTrials.gov registry entry for NCT01370122 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 225 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abramson Cancer Center at Penn Medicine, which has 402 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Survey is the first listed.
NCT01370122 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01370122 about?
NCT01370122 is a clinical study titled "Pelvic Floor Disorders in Survivors of Gynecologic Malignancies". Pelvic Floor dysfunction affects the quality of life of women. However, the prevalence and risk factors for pelvic floor disorders (PFD) in survivors of gynecologic malignancies are not known. The investigators plan to perform an observational study including survivors of gynecologic malignancies. Q...
What is the current status of trial NCT01370122?
This trial is currently completed. The enrollment target is 225 participants. The study started on 2011-05. Estimated completion is 2017-09.
What interventions are being tested in trial NCT01370122?
The interventions under investigation include: Survey (OTHER).
Who is sponsoring clinical trial NCT01370122?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.